A Study of Sovilnesib in Subjects With Ovarian Cancer

Clinical trial NCT06084416 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06084416
Sponsor: Volastra Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

High Grade Serous Adenocarcinoma of Ovary Fallopian Tube Cancer Primary Peritoneal Carcinoma Chromosomal Instability

Start date: 2024-04-04
Primary completion: 2026-03-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.